Skip to main content

ADVERTISEMENT

Shingo Kuwata, MD, PhD

Comparison in Clinical Outcomes Between Leadless and Conventional Transvenous Pacemaker Following Transcatheter Aortic Valve Implantation
09/30/2020
Atrioventricular block is a common complication of transcatheter aortic valve implantation (TAVI). Although conventional transvenous dual-chamber pacemaker (PM) is ideal for atrioventricular block, leadless PM is less invasive and may be...
Atrioventricular block is a common complication of transcatheter aortic valve implantation (TAVI). Although conventional transvenous dual-chamber pacemaker (PM) is ideal for atrioventricular block, leadless PM is less invasive and may be...
Atrioventricular block is a...
09/30/2020
Journal of Invasive Cardiology
“Avulsion Injury” of the Artery by a Suture-Mediated Closure System During Transcatheter Aortic Valve Implantation
Clinical Images
06/30/2020
We describe a cut-down method that is useful in cases with calcification restricted to the region surrounding the puncture site in transcatheter aortic valve implantation patients with severe aortic stenosis.
We describe a cut-down method that is useful in cases with calcification restricted to the region surrounding the puncture site in transcatheter aortic valve implantation patients with severe aortic stenosis.
We describe a cut-down method...
06/30/2020
Journal of Invasive Cardiology
Tanabe CI
Video
01/31/2022
The current guidelines recommend at least 6-month antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.” This is the first evaluation of PFO occluder device...
The current guidelines recommend at least 6-month antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.” This is the first evaluation of PFO occluder device...
The current guidelines recommend...
01/31/2022
Journal of Invasive Cardiology
Clinical Images
01/28/2022
The current guidelines recommend at least 6 months of antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.”
The current guidelines recommend at least 6 months of antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.”
The current guidelines recommend...
01/28/2022
Journal of Invasive Cardiology